Pharmaceuticals
Company Overview of InfaCare Pharmaceutical Corporation
Company Overview
InfaCare Pharmaceutical Corporation, a specialty pharmaceutical company, engages in the development and commercialization of pharmaceuticals for the neonatal and pediatric patient population. Its neonatal product, Stanate, is under development for the pharmacologic treatment of infantile jaundice or hyperbilirubinemia. The company was founded in 2005 and is based in Trevose, Pennsylvania.
8 Neshaminy Interplex
Suite 221
Trevose, PA 19053-6499
United States
Founded in 2005
Key Executives for InfaCare Pharmaceutical Corporation
Similar Private Companies By Industry
| Company Name | Region |
| Del Pharmaceuticals, Inc. | United States |
| NexGen Diagnostics LLC | United States |
| GlaxoSmithKline Consumer Healthcare, L.P. | United States |
| Spectra Stable Isotopes | United States |
| JoMo Nutrition USA, LLC | United States |
Recent Private Companies Transactions
| Type Date |
Target |
|
Private Placement
March 8, 2013 |
-- |
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Washington | AstraZenecaPosted: May 21
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact InfaCare Pharmaceutical Corporation, please visit infacare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
